Health sciences company PreveCeutical Medical Inc. (CSE:
PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the first product
development program of the company’s newly created medicinal cannabis division,
which will focus on the development of cannabinoids as a preventative treatment
for anxiety disorders using PreveCeutical’s proprietary Sol-gel delivery
platform. Per the update, the goal of the medical cannabis division’s program
is to “create an effective therapy for anxiety that can be administered subtly
and infrequently, addressing concerns of currently available treatments for
anxiety disorders.” According to data from the Mayo Clinic, common approaches
to treating anxiety, such as the prescription of selective serotonin reuptake
inhibitors, are not always effective and are known to have numerous side
effects, including insomnia, agitation and sexual dysfunction. Individuals who
experience these issues could benefit greatly from PreveCeutical’s Sol-gel
product development program.
To view the full press release, visit http://ibn.fm/xbVfs
About PreveCeutical Medical Inc.
PreveCeutical is a health sciences company that develops
innovative options for preventive and curative therapies utilizing organic and
nature identical products. PreveCeutical aims to be a leader in preventive
health sciences and currently has five research and development programs,
including: dual gene therapy for curative and prevention therapies for diabetes
and obesity; the Program; Nature Identical™ peptides for treatment of various
ailments; non-addictive analgesic peptides as a replacement to the highly
addictive analgesics such as morphine, fentanyl and oxycodone; and a
therapeutic product for treating athletes who suffer from concussions (mild
traumatic brain injury). PreveCeutical sells CELLB9®, an Immune System Booster.
CELLB9® is an oral solution containing polarized and potentiated essential
minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion
venom. This product is available on the company’s website. For more
information, visit the company’s website at www.PreveCeutical.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment